Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Clinical trial NCT00727194 · TERMINATED
Trial details
- NCT number
- NCT00727194
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-03-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.